{
    "Trade/Device Name(s)": [
        "Procise CRP Assay Kit",
        "ProciseDx Instrument",
        "ProciseDx Calibration Cartridge",
        "ProciseDx Analyzer",
        "Procise C-Reactive Protein",
        "Procise CRP"
    ],
    "Submitter Information": "ProciseDx, Inc.",
    "510(k) Number": "K201256",
    "Predicate Device Reference 510(k) Number(s)": [
        "K142993"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DCK"
    ],
    "Summary Letter Date": "August 4, 2022",
    "Summary Letter Received Date": "August 5, 2022",
    "Submission Date": "October 24, 2022",
    "Regulation Number(s)": [
        "21 CFR 866.5270"
    ],
    "Regulation Name(s)": [
        "C-reactive protein immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology",
        "chemistry"
    ],
    "Analyte(s)": [
        "C-Reactive Protein (CRP)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ProciseDx Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Fluorescence resonance energy transfer (FRET)",
        "Immunoassay"
    ],
    "Methodologies": [
        "Competitive immunoassay",
        "Time-resolved fluorescence energy transfer"
    ],
    "Submission Type(s)": [
        "Assay",
        "Analyzer",
        "Calibration Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for ProciseDx CRP time-resolved fluorescence energy transfer immunoassay for quantitative C-reactive protein measurement in human serum using the ProciseDx Analyzer.",
    "Indications for Use Summary": "Quantitative determination of C-reactive protein (CRP) levels in human serum to aid in evaluation of injury, infection, and inflammatory disorders; performed on the ProciseDx Analyzer by clinical laboratory professionals for in vitro diagnostic use only.",
    "fda_folder": "Immunology"
}